Pancreatic cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up

Annals of Oncology

Volumn 19, Issue SUPPL. 2, 2008, Pages

  Herrmann, R ^a,c   Jelic, S ^b,c  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

^c ESMO HEAD OFFICE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; GEMCITABINE;

ADVANCED CANCER; ARTICLE; BOLUS INJECTION; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; EUROPEAN UNION; FOLLOW UP; HISTOPATHOLOGY; HUMAN; METASTASIS; OVERALL SURVIVAL; PANCREAS BIOPSY; PANCREAS CANCER; PANCREAS RESECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT RESPONSE; INCIDENCE; PANCREAS TUMOR; PATHOLOGY;

FOLLOW-UP STUDIES; HUMANS; INCIDENCE; NEOPLASM STAGING; PANCREATIC NEOPLASMS;

EID: 45149119194     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdn076     Document Type: Article

References (6)

1. Burris HA, Moore MJ, Andersen J et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreatic cancer: A randomized trial. J Clin Oncol 1997; 15: 2403-2413.
2. John TG, Greig JD, Carter DC et al. Carcinoma of the pancreatic head and periampullary region. Tumor staging with laparoscopy and laparoscopic ultrasonography. Ann Surg 1995; 221: 156-164.
3. National Comprehensive Cancer Network: www.nccn.org(date last accessed 26 February 2005).
4. Klinkenbijl JH, Jeekel J, Sahmoud T et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: Phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 1999; 230: 776-782.
5. Neoptolemos JP, Stocken DD, Friess H et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004; 350: 1200-1210.
6. Neoptolemos JP, Stocken DD, Dunn JA et al. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg 2001; 234: 758-768.